Tag: Nerivio
Newly published study shows preventative benefits of Nerivio wearable in adolescents...
Theranica has announced the peer-reviewed publication of a comprehensive clinical study showing the preventive benefits of its remote electrical neuromodulation (REN) wearable, Nerivio, for...
Theranica announces new study indicating meaningful impact of Nerivio from as...
Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only...
Nerivio demonstrates real-world effectiveness as migraine treatment in adolescents
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology....
Drug-free migraine treatment gains additional US FDA clearance for preventative use
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive...
Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial
Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...
Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine
Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...
Theranica secures US$45 million through Series C funding round
Theranica has announced the closing of its Series C funding round, with a first closing of US$45 million. New Rhein Healthcare Investors led the...
Study shows positive impact of new in-app feature on Nerivio REN...
A new peer-reviewed study published in Pain Medicine, examining the use of Nerivio’s (Theranica) guided imagery, education and relaxation (GIER) in-app optional behavioural intervention...
Large real-world analysis deems Nerivio safe and effective in migraine treatment
Theranica has announced a new peer-reviewed study analysing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication-adjunct, treatment...
Study indicates safety and efficacy of remote electrical neuromodulation in chronic...
Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...
